---
layout: post
title: "港股医药股持续走高"
date: 2022-05-20 13:48:14 +0800
categories: cailianshe
tags: 财联社新闻
---
<!-- EM_StockImg_Start --><p style="text-align:center;"><a href="http://quote.eastmoney.com/unify/r/116.06185" data-code="06185|116|5" data-code2="06185|116|3|" class="EmImageRemark" target="_blank"><img src="https://webquoteklinepic.eastmoney.com/GetPic.aspx?nid=116.06185&imageType=k&token=28dfeb41d35cc81d84b4664d7c23c49f&at=1" border="0" alt="K图 06185_0" data-code="K 06185|116|5" data-code2="K 06185|116|3|" style="border:#d1d1d1 1px solid;" width="578" height="276" /></a></p><!-- EM_StockImg_End --><p> 港股医药股持续走高，荣昌生物、康希诺生物涨超10%，华领医药涨超9%，亚盛医药涨超8%，药明生物、泰格医药涨近7%，再鼎医药涨超6%，和黄医药、康宁杰瑞制药涨近6%，昭衍新药涨超5%，百济神州、金斯瑞生物科技涨近4%，消息面上，国务院办公厅印发“十四五”国民健康规划，规划提出完善国家药品标准体系。</p><p class="em_media">（文章来源：财联社）</p>

<http://finews.zning.xyz/html_News/NewsShare.html?infoCode=NW202205202386399250>

[返回财联社新闻](//finews.withounder.com/category/cailianshe.html)｜[返回首页](//finews.withounder.com/)